2003 Help me understand this report
997 Triple therapy compared to standard pegylated interferon alfa 2B + weight based ribavirin for treatment naive chronic hepatitis C[tri-star trial]: final results
Search citation statements
Paper Sections
Select...
1
Citation Types
0
1
0
Year Published
2004
2004
Publication Types
Select...
1
Relationship
0
1
Authors
Journals
Cited by 1 publication
(1 citation statement)
References 0 publications
0
1
0
“…There was no significant effect of double therapy [97][98][99][100][101][102][103][104][105]109,111,112,116,118,119,123,127] on ETR, with a mean difference of 3.1% (95% CI: K1 to 7.3%, PZ0.1), and on SR with a mean difference of 4% (95% CI: K3.3 to 4.3%, PZ0.8). Triple therapy [106][107][108]110,[113][114][115][116][117][120][121][122][124][125][126] had a significant effect on ETR (Fig. 1) with a mean difference of 12% and on SR (Fig.…”
Section: Amantadine Effect On Overall Patientsmentioning
confidence: 99%
“…There was no significant effect of double therapy [97][98][99][100][101][102][103][104][105]109,111,112,116,118,119,123,127] on ETR, with a mean difference of 3.1% (95% CI: K1 to 7.3%, PZ0.1), and on SR with a mean difference of 4% (95% CI: K3.3 to 4.3%, PZ0.8). Triple therapy [106][107][108]110,[113][114][115][116][117][120][121][122][124][125][126] had a significant effect on ETR (Fig. 1) with a mean difference of 12% and on SR (Fig.…”
Section: Amantadine Effect On Overall Patientsmentioning
confidence: 99%
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
